...
首页> 外文期刊>Biotechnology Letters >Intracellular drug delivery using poly(D,L-lactide-co-glycolide) nanoparticles derivatized with a peptide from a transcriptional activator protein of HIV-1
【24h】

Intracellular drug delivery using poly(D,L-lactide-co-glycolide) nanoparticles derivatized with a peptide from a transcriptional activator protein of HIV-1

机译:使用聚(D,L-丙交酯-共-乙交酯)纳米颗粒的细胞内药物递送,该纳米颗粒由来自HIV-1转录激活蛋白的肽衍生而来

获取原文
获取原文并翻译 | 示例

摘要

Biodegradable poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles were derivatized with Tat(49-57) peptide, which is the protein transduction domain from the transcriptional activator Tat protein of human immunodeficiency virus type-1 (HIV-1). The Tat(49-57) peptide-modified PLGA nanoparticles, with a mean diameter of ca. 238 nm, was effectively adsorbed on to the membrane of HaCaT cells and delivered into the nuclei without cytotoxicity. [References: 15]
机译:Tat(49-57)肽衍生了可生物降解的聚(D,L-丙交酯-共-乙交酯)(PLGA)纳米颗粒,Tat(49-57)肽是人免疫缺陷病毒1型(HIV- 1)。 Tat(49-57)肽修饰的PLGA纳米粒子,平均直径约为。 238 nm被有效地吸附到HaCaT细胞膜上,并被传递到细胞核中而没有细胞毒性。 [参考:15]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号